



Arh. farm. 2020; 70:344 – 359 Original scientific paper/Originalni naučni rad 
 
Toxicity of Organic and Inorganic Nickel in 
Pancreatic Cell Cultures: Comparison to Cadmium 
 
David R Wallace*1, Aleksandra Buha-Djordjevic2, Alexander Benton3 
 
1Oklahoma State University Center for Health Sciences, School of Biomedical Sciences 
and Interdisciplinary Toxicology Program, 1111 West 17th Street, Tulsa Oklahoma, 
74107-1898 United States 
2 University of Belgrade - Faculty of Pharmacy, Department of Toxicology “Akademik 
Danilo Soldatović”, Vojvode Stepe 450, 11221 Belgrade, Serbia 
3 Oklahoma State University, Department of Biochemistry and Molecular Biology, 
Program in Biochemistry and Molecular Biology, Noble Research Center, Stillwater, 
Oklahoma, 74078 United States 
 
*Corresponding Author: David R Wallace,  E-mail: david.wallace@okstate.edu 
 
Abstract 
Nickel compounds are Group 1 carcinogens and possibly cancer-causing in the pancreas. 
We examined the toxicity of nickel in both 2-D and 3-D pancreatic cell cultures, to determine the 
LD50 for organic and inorganic nickel in normal and cancerous cells. Assays with cadmium 
chloride were performed to be a comparison to potential nickel-induced toxicity. Cells were 
exposed to twelve concentrations of NiCl2 or Ni-(Ac)2 for 48h (2-D), or six concentrations for 48 
hours (3-D). There was a significant (P=0.0016) difference between HPNE and AsPC-1 LD50 
values after cadmium exposure, at 69.9 µM and 29.2 µM, respectively. Neither form of nickel 
exhibited toxicity in 2-D or 3-D cultures, but after 48h, changes in spheroid morphology were 
observed. The inability of Ni to reduce viable cell numbers suggests a toxic mechanism that 
differs from cadmium, also a Group 1 carcinogen. The cell microenvironment was not a factor in 
nickel toxicity with no changes in viable cells in either 2-D or 3-D cultures. These studies only 
examined cytotoxicity, and not genotoxicity, a potential mechanism of nickel carcinogenicity. 
Alterations in DNA function or the expression of apoptotic proteins/processes would take longer 
to manifest. Current work focuses on cellular changes following extended nickel exposure.  
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Nickel (Ni) is a ubiquitous metal found naturally in the environment and associated 
with manufacturing and commercial processes (1). Our understanding of Ni-related 
toxicity has linked Ni exposure to multiple disease states (2,3). Exposure to Ni may also 
occur by consumption of contaminated foods or agricultural products (4,5). Besides 
contaminating sources such as commercial items, a major source of Ni is through vaping 
and the inhalation of Ni contaminated vapor (6,7). Numerous reports have linked 
exposure to Ni through processes like welding, electroplating, and painting (8–11). Of 
the metals that fall within the broad category of ‘heavy metals,’ Ni has been understudied 
compared to metals like mercury, lead, cadmium (Cd), and manganese. Cd and Ni are 
often found together in the environment. Both metals have been shown to bind to soil 
humic substances, which facilitates the joint movement of the metals through the 
environment (12). Ni has presented an insidious health risk with symptoms not presenting 
for months/years after exposure. It has been shown that Ni accumulates in different organ 
systems at different rates. The lungs and thyroid are areas rich (140-170 μg/kg) in Ni, 
whereas the pancreas has one of the lowest Ni content at 34 μg/kg (range of 7-71 μg/kg) 
in humans (13). Ni is not readily cleared from the body and may bioaccumulate, posing 
additional health risks. Recent evidence suggests that Ni exposure may result in 
endocrine-related changes, including tumor formation (14–16).  Similar to Cd, Ni has 
been suspected of acting as a metalloestrogen, activating the estrogen ERα receptor, but 
overall, the information is scarce (17). A critical action of Ni-mediated toxicity has been 
reported to be the generation of free radicals and the promotion of oxidative stress (18–
20), leading to an increase in lipid peroxidation (21). 
 Pancreatic cancer (PC) is one of the most lethal human cancers and an important 
cause of cancer-associated-mortalities worldwide (22,23). The primary environmental 
factors associated with PC so far are inhalation of cigarette smoke, exposure to mutagenic 
nitrosamines, chlorinated hydrocarbon solvents, and heavy metals (24).  Involuntary 
exposure to heavy metals in humans, particular attention to Cd, is important due to its 
abundance as an occupational and environmental pollutant (25). Previous studies have 
linked Cd exposure and PC development due to Cd accumulation in the pancreas (26,27). 
We chose to use Cd as a form of internal control based on its known ability to cause cell 
death and promote pancreatic cancer pathogenesis. Global health organizations have 
listed both Cd and Ni as class I carcinogens (28,29). Reviews from different groups have 
outlined the mechanisms associated with metal- and metalloid-induced toxicity leading 
to cancer development (16,29,30). A positive correlation between Cd concentration and 
the incidence of PC has been reported for samples taken from toenails (31). However, 
there was a negative correlation between Ni concentration and PC incidence (31). A 
similar negative correlation for Ni concentration in the pancreas has been reported in early 




correlate with cancer incidence; instead elevated Ni content correlates with elevated 
chromium in the pancreatic juice (28,33). This secondary correlation suggests an indirect 
involvement of Ni. 
 Historically available technology limited cell culture work. Work in two 
dimensions (2-D) predominates the literature. Recently, technology has permitted the 
development of cell culture work in three dimensions (3-D). Multiple platforms exist for 
developing 3-D cultures, including the use of specialized 96-well plates with concave 
wells, which is our model system (34–36). The technologies available are outlined in 
numerous reviews, and these authors stress the importance of the 3-D model in capturing 
the complexity associated with the naturally occurring tumor environment (37–40). Since 
3-D methodologies are relatively new, most of the literature published is over the last five 
years. Literature describing the use of 3-D culture for the study of PC is scarce. There 
have been no reports describing HPNE cells in 3-D culture, and publications describing 
the AsPC-1 cells in culture are few (34,41,42). This lack of information is one of the 
foundations for the importance of the studies presented here.   
 To best determine toxicity following metal exposure, the appropriate cell 
microenvironment was utilized. There are limitations with the conventional 2-D culture 
methods, with 3-D cultures being touted as a good alternative to 2-D culture models. We 
aim is to develop and use assay conditions that further our understanding of PC biology 
in 3-D cultures and establish criteria for studying toxic mixtures of environmental 
toxicants. The goal of these studies is to compare the effects of nickel chloride (NiCl2) or 
nickel acetate (Ni-(Ac)2) on the viability of HPNE and AsPC-1 pancreatic cells. Two 
growth methodologies are utilized (2-D v. 3-D) to examine the effects of cell 
microenvironment on the cellular response to NiCl2 exposure. 
 Collectively, these studies are the first to compare the development and 
functionality of spheroids for the HPNE and AsPC-1 cell lines and examine Ni-mediated 
toxicity in both 2-D and 3-D cultures. As the current methodology improves, the use of 
spheroids to accurately mimic the milieu of the tumor will be vital.   
Methods 
Cell Lines and Cell Culture Maintenance: Cell lines were obtained from American 
Type Culture Collection (ATCC, Manassas, VA). Pancreas hTERT-HPNE (“Human 
Pancreatic Nestin-Expressing”; ATCC® CRL-4023™, immortalized control pancreatic 
cells – referred to as ‘HPNE’) and AsPC-1 (ATCC® CRL-1682™, pancreatic tumor 
cells) were grown and maintained, as described in ATCC protocols. Cells were 
maintained at 37°C with 5% CO2. hTERT-HPNE cell line is a control human pancreatic 
ductal cells that were transfected with the hTERT gene using the retroviral expression 




Cell Treatment: Cells were initially grown in a 25cm2 flask to near confluence 
having reached their exponential growth phase. Cells were then trypsinized, removed, 
and subjected to Trypan Blue cell counting using a Corning® CytoSMART cell counter. 
Cells were diluted in growth media to a final concentration of 105 cells/mL before the 
addition of 100 μL of cell suspension per well. Cells were returned to the incubator for 
24h, after which the media was removed, and assay media (MEM with 1% FBS; no 
phenol) was added with the appropriate concentration of NiCl2 or Ni-(Ac)2 and the 
exposure to Ni was continued for 48h. 
3-D Spheroid Culture Growth: Cells were maintained using conventional methods 
and grown in a 25cm2 flask (approximately 80% confluent; the exponential part of the 
growth phase). Cells were trypsinized for removal from the flask, and media was added 
to yield a final concentration of approximately 2.5x104 cells/well. To promote orderly 
spheroid growth, clumps of cells must be removed from suspension. To facilitate this, 
suspensions were passed through a 40-μm cell strainer to yield a homogenous population 
of single cells. A 100 μL aliquot of the ‘single-cell’ suspension was placed in each well 
and spheroid formation was observed at 24h and 48h. Cells were grown in their normal 
growth media using specialized concave microsphere plates (Corning, Model #4515). 
Cell Viability Measurements in 2-D cultures – MTT assay: MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) stock solutions were prepared 
by adding sterile PBS to a final concentration of 12.5 mM MTT. Stock MTT was diluted 
in-well by the addition of 10 µL of MTT stock to each well (1.1 mM final concentration). 
Plates were returned to the incubator for 4 hours. After incubation, 50 µL of DMSO was 
added to each well to solubilize MTT crystals, and the plates were returned to the 
incubator for 10 min. Absorbance was measured using a BioTek plate reader at 540 nm. 
Cell Viability Measurements in 3-D Spheroids: Only the AsPC-1 cells were utilized 
in this study due to the improved spheroid formation in the tumor cells compared to HPNE 
cells. Viability measurements were obtained using the CellTiter-Glo®-3D assay kit 
(Promega) as described in the manufacturer’s guidelines and protocol. Following 
exposure to NiCl2 for 48h, assays were performed following the manufacturer protocol. 
Incubation was carried out at room temperature (22°C) for 25 minutes, and the resulting 
ATP-related luminescence was measured at 590 nm using a BioTek plate reader. 
Statistical Analysis: All data were analyzed using the non-normalized data using a 
one-way ANOVA, followed by Dunnett’s-test for posthoc comparisons of treatment 
groups to control. LC50 values were analyzed by a two-tail t-test. All analyses and 
graphics were generated using GraphPad Prism (v8.4.3; GraphPad, San Diego, CA). Data 







3-D Spheroid Culture Growth: Both HPNE control cells and AsPC-1 tumor cells 
were grown in the specialized concave culture plates designed specifically for spheroid 
development (Figure 1). It was clear from the images and dilutions at both 24h and 48h 
incubation times that the AsPC-1 tumor cells formed spheroids with greater definition 
than HPNE cells. At the maximum (104 cells/well; 100%) concentration, a clearly defined 
spheroid was evident after 24h in the AsPC-1 group.  HPNE cells didn’t form a 
conventional spheroid but instead formed a dense, asymmetrical ‘clump.’ Further 
examining cell dilutions, 50% (5,000 cells/well), 25% (2,500 cells/well), 12.5% (1,250 
cells/well) and 6.25% (625 cells/well) demonstrated that the AsPC-1 group formed 
spheroids even at the lowest concentration of cells, but the spheroid was less defined than 
with dilutions higher than 25%. 
 
Figure 1. Culture dilution comparison of spheroid formation in pancreatic tumor (AsPC-1)  
  and control (HPNE) cells. 100% suspension represents all cells from a 25cm2 flask  
  (~106 cells/mL), the entire cell suspension was added to 10 mL of growth media prior 
  to passage through a 40-μm cell strainer to achieve single cell suspensions and  
  facilitate normal spheroid development. Plates were returned to the incubator  
  (37°C/5% CO2) for 24 and 48 hours. 
Slika 1.  Poređenje formiranja sferoida u tumorskim ćelijama pankreasa (AsPC-1) i  
  kontrolnim (HPNE)  ćelijama. 100% suspenzija predstavlja sve ćelije iz suda  
  zapremine 25  cm2  (~ 106 ćelija / ml), celokupna ćelijska suspenzija je dodata u                      
  10 ml medija za rast pre prolaska kroz filter od 40 μm, a da bi se postigle suspenzije 
  pojedinačnih ćelija i olakšao normalan razvoj sferoida. Ploče su vraćene u inkubator 




Determination of LC50 values for Cd and Ni: Incubating HPNE and AsPC-1 cells 
with increasing concentrations of CdCl2 (100 nM – 10 mM) resulted in reduced viability 
at the higher concentrations (Figure 2). Using the Least Squares Fit model, nonlinear 
regression analysis resulted in a converging fit for HPNE (R2 = 0.9814) and AsPC-1 (R2 
= 0.9496) cells and provided LC50 for each run. To determine if ‘within group’ variance 
contributes to the ‘between-group’ differences, the D’Agostino-Pearson (K2) test was 
utilized, and both HPNE (K2 = 0.2595) and AsPC-1 cells (K2 = 0.4752) passed the 
normality test. Comparing the LC50 values (Figure 2, inset) revealed HPNE cells 
exhibited a significantly (p = 0.0016) higher LC50 value (69.9 ± 9.1 μM) compared to 
AsPC-1 cells (29.2 ± 2.7 μM). 
 
Figure 2.  Reduction in cell viability following exposure to increasing cadmium concentrations 
  for 48 hours. HPNE and AsPC1 cells were incubated with six concentrations  
  (100nM – 10mM) cadmium chloride were incubated with HPNE or AsPC-1 cells,  
  and the MTT assay was used to determine cell viability.  Data are expressed as the  
  mean ± SEM of six (n=6) experiments performed in duplicate and were analyzed  
  using GraphPad Prism (v.8.4.3) nonlinear regression to determine individual LC50  
  values. LC50 data is represented in the insert and is expressed as the mean ± SEM. * 
  represents significantly (P=0.0016) different from HPNE cell values. 
 
Slika 2. Smanjenje ćelijske vijabilnosti nakon izloženosti rastućim koncentracijama  
  kadmijuma tokom 48 sati. HPNE ili AsPC-1 ćelijske kulture inkubirane su sa šest  
  rastućih koncentracija (100nM – 10mM) kadmijum hlorida. MTT esej je korišćen  
  za utvrđivanje vijabilnosti ćelija. Podaci su izraženi kao srednja vrednost  ±  
  standardna greška šest eksperimenata izvršenih u duplikatima i analizirani su  
  pomoću GraphPad Prism (v. 8.4.3) upotrebom nelinearne regresije za utvrđivanje  
  pojedinačnih LC50 vrednosti. Podaci o LC50 vrednostima su predstavljeni u umetku 
  i izraženi su kao srednja vrednost ± standardna greška. * predstavlja značajnu  




HPNE and AsPC-1 cells with increasing concentrations of NiCl2 (100 nM – 10 mM; 
Figure 3, top panel) or Ni-(Ac)2 (100 nM – 10 mM; Figure 3, bottom panel). Like 
measuring CdCl2 response, nonlinear regression analysis using the Least Squares Fit 
model following NiCl2 exposure resulted in a converging fit for HPNE (R2 = 0.9780) and 
AsPC-1 (R2 = 0.8886) cells and provided LC50 for each run. Variance within the NiCl2 
group resulted in a significant D’Agostino-Pearson (K2) test in AsPC-1 cells (K2 = 
19.52), but not in the HPNE (K2 = 0.9983) group, which passed the normality test. 
Variances that fail the test for normality suggest that the data does not follow conventional 
Gaussian distribution. Comparing the LC50 values (Figure 3, top inset), HPNE cells 
exhibited a slightly higher, but nonsignificant, LC50 value (1.15 ± 0.11 mM) compared to 
AsPC-1 cells (0.86 ± 0.13 mM). Using the same analysis model for the Ni-(Ac)2 exposure 
group, both curves converged for HPNE (R2 = 0.9090), and AsPC-1 (R2 = 0.8720) cells, 
and each assay provided LC50 values. Variance within data from both cell lines resulted 
in a significant D’Agostino-Pearson (K2) test in both AsPC-1 cells (K2 = 15.54) and 
HPNE (K2 = 9.963) groups. Comparing the LC50 values (Figure 3, bottom inset), the 
LC50 values for the HPNE group (0.68 ± 0.13 mM) were not different compared to the 
AsPC-1 group (0.53 ± 0.03 mM). Generally, the LC50 values for the Ni compounds were 
about 10- to 20-fold higher than for Cd, ranging from 69 μM to 1.15 mM in HPNE cells 
and from 29 μM to 860 μM in AsPC-1 cells.  
Ni-mediated changes in viability in AsPC-1 spheroid cultures: AsPC-1 cells were 
grown in spheroid culture as described in the methods. Plates were returned to the 
incubator for 24h at which time the media was removed, assay media added, and the 
photomicrograph (10x) taken, representing the 0h time point (Figure 4, left panel). Note 
the yellow circle on each panel encompassing the spheroid. The same circle is positioned 
on the right side of the image, 48h after exposure to 50 μM NiCl2 or Ni-(Ac)2. We 
observed that after 48h of exposure, there did not appear to be a reduction in cell number, 
but the spheroids lost their organized structure, starting on the outer layers of the spheroid. 
Measuring the cell viability in the spheroid, we observed no noticeable reduction in 
viability or ATP release following one-way ANOVA analysis examining the effect of 
treatment (Figure 4, right panel). The rationale for using 50 μM NiCl2 or Ni-(Ac)2 was 
to examine the low concentration effects. By modifying the equation for fractional 
occupancy (eq. 1) for LC50, we can derive an estimate of the lethality based on the metal 
concentration and its LC50 value. 




Using this modified equation, we can estimate the cell lethality for 50 μM NiCl2 to 
be 5.5%, and for Ni-(Ac)2, the lethality is 8.6%. In both instances, low lethality would be 
within the error of the viability assay. Although viability was low, exposure to Ni 





Figure 3.  Minimal reduction in cell viability following exposure to increasing nickel chloride  
  (top panel) or acetate (bottom panel) after 48 hours. Twelve concentrations  
  (100nM – 10mM) of nickel chloride or nickel acetate were incubated with HPNE or 
  AsPC-1 cells, and the MTT assay was used to determine cell viability following  
  exposure for 48 hours. Data are expressed as the mean ± SEM of eight (n=8)  
  experiments performed in duplicate and analyzed using GraphPad Prism (v.8.4.3)  
  nonlinear regression to determine individual LC50 values. LC50 data is represented  
  in the insert and is expressed as the mean ± SEM. 
Slika 3.  Minimalno smanjenje održivosti ćelija nakon izlaganja rastućim koncentracijama  
  nikl-hlorida (gornja ploča) ili acetata (donja ploča) nakon 48 sati. HPNE ili AsPC-1 
  ćelijske kulture inkubirane su sa dvanaest rastućih koncentracija  (100 nM - 10 mM) 
  nikl hlorida ili nikl acetata. MTT test je korišćen za određivanje  vijabilnosti ćelija  
  nakon izlaganja tokom 48 sati. Podaci su izraženi kao srednja vrednost ±  
  standardna greška osam eksperimenata izvedenih u duplikatu i analizirani su  
  pomoću GraphPad Prism (v. 8.4.3) upotrebom nelinearne regresije za utvrđivanje  
  pojedinačnih LC50 vrednosti. Podaci o LC50 vrednostima su predstavljeni u umetku 




Figure 4.  Analysis of nickel cytotoxicity in AsPC-1 3-D cultures. Cells were grown and  
 plated in the Corning 96-well plates designed for promoting spheroid formation  
 as described in the ‘Methods’. Cells began spheroid formation within 24 h, and  
 the initial photograph (Leica inverted scope, 5x objective) was taken. Cells were  
 exposed to media (control), 50µM NiCl2, or 50µM Ni-acetate for 48h. Another  
 photomicrograph was taken, and cell viability was determined using Promega’s  
 CellTiter-Glo assay. Luminescence was measured at 590nm (determined as  
 optimum signal/noise). Data are expressed as the means ± SEM of 4 assays  
 performed in duplicate (n=4). 
 
Slika 4. Analiza citotoksičnosti nikla u AsPC-1 3-D ćelijskim kulturama. Ćelije su uzgajane  
 u Corning  pločama sa 96 mesta dizajniranim za promovisanje sferoidnih  
 formacija kao što je opisano u delu Metode. Ćelije su započele sferoidno  
 formiranje u roku od 24 h i snimljena je inicijalna fotografija. Ćelije su bile  
 izložene medijima: kontrolnom, 50 μM nikl-hlorida ili 50 μM nikl-acetata tokom  
 48h. Snimljen je još jedan fotomikrograf , a vijabilnost ćelija određena je  
 korišćenjem Promega’s CellTiter-Glo eseja.  Luminescencija je izmerena na  
 590nm (optimalni odnos signal/buka). Podaci su izraženi kao srednja vrednost                    







Our previous studies have established a body of evidence that strongly suggests that 
Cd is toxic in the pancreas and may lead to the development of pancreatic cancer, and 
other physiological dysfunctions such as insulin dysregulation and thyroid dysfunction 
(44–47). Ni and Ni-containing compounds have not been studied to the same extent as 
Cd. As a result, the primary aim of this study was to begin an investigation into Ni-
mediated toxicity in the pancreas. Also, we initiated studies to compare the actions of 
toxicants in 2-D versus 3-D cell culture. There are subtle differences between toxicant 
responses in the two systems (35,36). In particular, the pancreas has become an organ 
system critical for the development of 3-D model systems to be used in cancer studies 
(42). To date, few studies have utilized 3-D cultures in the study of PC, and none have 
examined Ni’s effects following short-term exposure. 
Using Cd toxicity as an internal assay control to assess Ni-mediated toxicity was 
done to validate our assay conditions. The determination of LC50 values for Cd was 
similar to what we have previously reported (47). Contrary to our findings with Cd, the 
toxicity of Ni was minimal in the initial 2-D studies. Our LC50 values were 10-20-fold 
higher than for Cd (> 500 μM). The present studies lay the foundation for a future 
examination into the cellular effects of Ni-mediated toxicity. 
On the surface, the relatively low lethality associated with either NiCl2 or Ni-(Ac)2 
exposure for 48h would suggest a generalized lack of toxicity associated with Ni. These 
findings are supported by current literature describing Ni-mediated effects in a variety of 
model systems. In rodent β-cells, exposure to NiCl2 for 24h did not elicit a significant 
reduction in viability until the test concentration exceeded 1 mM (15). In mouse and 
human cell lines, NiCl2 exposure elicits an interesting profile of toxicity. In mouse cells, 
lower concentrations of Ni (100-200 μM) increased viability compared to control values, 
but at 600-800 μM, there was a nearly 50% reduction in viability (48). In human HepG2 
cells, increasing Ni concentration, resulted in decreasing viability, with a 50% reduction 
at 400-600 μM (48). In human lymphocytes, significant reductions in viability were not 
observed until a concentration of 3 mM was exceeded (18). The viability reports in the 
literature support our findings of LC50 values of >500 μM dependent on the cell line and 
the chemical form of Ni (organic or inorganic). Although not overtly toxic, further studies 
will be needed to investigate long-term exposure to Ni. 
One of the mechanisms of Ni-induced toxicity is the promotion of oxidative stress. 
When the current information is examined, it is evident that Ni’s ability to induce free 
radical generation is about as potent as its lethality. In vivo models using injections of 
moderately high Ni doses resulted in increased expression/activity of various biomarkers. 
These biomarkers are associated with oxidative stress such as alkaline phosphatase, 
aspartate transaminase, oxidized lipids, malondialdehyde, or glutathione reduction 
(20,49,50). A study by Chen et al. (18) generation of free radicals following NiCl2 
administration showed that dichlorofluorescein fluorescence was not elevated until a 




promoter of oxidative stress. Exposure duration was only 1h, which for an in vitro assay 
would be sufficient for significant radical generation, only yielded a 3-fold increase in 
oxidative stress over baseline (18). Even if Ni is a weak free radical generator, the in vivo 
studies leave open the possibility that a second pathway is involved. Ni administration 
may work through multiple pathways to increase oxidative stress. 
Although Ni is considered a carcinogen, it has been shown to exhibit an inverse 
correlation between Ni content and the incidence of PC (31,32). One report demonstrated 
a positive correlation between Ni content and PC involving KRAS mutations (51). There 
is a mounting body of evidence that supports Ni involvement in an array of pancreas-
related dysfunction. Application of Cd to β-cells elicits responses mediated by the L-type 
(long-lasting) calcium channels, whereas Ni works through the transient T-type calcium 
channels (52). When Ni is applied to β-cells, there was no response in calcium flux or 
insulin release suggesting a lack of T-type channels on β-cells. Yet, there is a mechanism 
for Ni-induced damage in the pancreas. Parental exposure to NiCl2 results in an increase 
in oxidative stress markers in the pancreas (14). Ni itself appears to be a ‘hyperglycemic’ 
metal, a metal that promotes blood glucose elevation, either by reducing insulin release, 
blocking insulin action, or promoting glycogen breakdown/de novo glucose synthesis. 
The in vivo result of Ni exposure is hyperglycemia resembling diabetes and may involve 
other mediators (21,53,54).  
Collectively, these studies provide the foundation and the initial set of data that we 
can build from moving forward in our study of Ni toxicity and its involvement in PC 
development. The use of 3-D cultures is critical for furthering our understanding of metal- 
or Ni-induced toxicity and PC development. The tumor cells tend to form very distinct 
and orderly spheroids. In the concave well model, control HPNE cells tended to form 
more of a dense cluster that doesn’t resemble the archetypical spheroid. A different model 
system may be needed, with the use of Matrigel® or magnetic microbeads as potential 
options that would by-pass the need for the cells to initiate their spheroid formation. 
Initially, it appears that our LC50 values were low, but when compared to the literature, 
Ni is not a highly lethal metal. Concentrations > 500 μM are needed to elicit an increase 
in free radical formation or cell death. Interestingly, it appears that Ni may be involved 
with other metals or toxicants, and the relationship between the different toxicants will 
direct the toxic outcome. The theory of chemical mixture toxicity needs to be explored 
further. Future studies are already underway characterizing cellular changes involving 
apoptotic pathways following Ni exposure. Another interesting avenue to pursue is Ni 
exposure resulting in epigenetic changes (55–58). As technology continues to develop 
and advance, we will continue to advance our understanding of Ni-mediated toxicity and 
Ni involvement in PC development. 
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Uloga nikla, toksičnog metala, u nastanku karcinoma pankreasa još uvek nije u potpunosti 
ispitana. Cilj rada je da ispita toksičnost nikla  (Ni)  u 2-D i 3-D kulturi ćelija pankreasa, kako bi  
se utvrdila LD50  vrednost za organski i neorganski nikl u normalnim i tumorskim ćelijama. 
Ispitivanja su izvršena i sa kadmijumom (Cd), metalom čija je uloga u nastanku karcinoma 
pankreasa potvrđena u prethodnim istraživanjima, a u svrhu poređenja sa potencijalnom 
toksičnošću izazvanom Ni. Ćelije su bile tretirane sa 12 različitih koncentracija NiCl2 ili Ni-(Ac)2 
tokom 48h  (2-D), odnosno sa šest različitih  koncentracija tokom 48 sati (3-D). Nijedan oblik Ni 
nije ispoljio toksičnost u 2-D ili 3-D kulturama, ali nakon 48h primećene su promene u sferoidnoj 
morfologiji. Nemogućnost Ni da smanji broj vijabilnih ćelija sugeriše mehanizam  karcinogeneze 
različit od mehanizma koji ispoljava Cd. Ipak, da bi se uočile izmene u funkciji DNK ili 
izražavanju apoptotičkih proteina/procesa potrebno je duže vremena, pa su dalja istraživanja 
upravo fokusirana na ćelijske promene nakon produžene izloženosti nikla. 
 
Ključne reči: nikl; kadmijum; citotoksičnost; toksični metali; karcinom 
 
